CHARACTERIZATION OF A CLASS OF PEPTIDE BORONATES WITH NEUTRAL P1 SIDE-CHAINS AS HIGHLY SELECTIVE INHIBITORS OF THROMBIN

被引:50
|
作者
DEADMAN, JJ
ELGENDY, S
GOODWIN, CA
GREEN, D
BABAN, JA
PATEL, G
SKORDALAKES, E
CHINO, N
CLAESON, G
KAKKAR, VV
SCULLY, MF
机构
[1] Thrombosis Research Institute, London SM2 5TF
关键词
D O I
10.1021/jm00009a012
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Z-D-Phe-Pro-boroMpg-OPin (9a)(1,2) has been shown previously to be a highly specific inhibitor of thrombin in spite of lacking an arginine-like guanidino group at the P1 site.(1) A range of compounds have been synthesized based upon this lead compound, varying the neutral side chain at the P1 site. Of the 20 examples based upon the structures at P2 and P3 of Z-D-X-Pro (X being Phe or beta,beta-diphenylalanine), all were found to be effective inhibitors of thrombin (K-i's between 10 and 100 nM). Furthermore all exhibited a high specificity toward thrombin having values for st K-i(trypsin)/K-i(thrombin) ratio of between 10- and 100-fold. High ratio values were found for a number of the compounds tested against a range of serine proteinases (plasmin, factor Xa, kallikrein, urokinase, protein Ca, chymotrypsin, elastase, and cathepsin G).(2) AS far as potency toward thrombin, compounds containing the methoxypropyl group at P1 were favored over those with a methoxy grouping on a shorter alkyl chain (8) or without the methoxy group (1-5). The compounds display potent anticoagulant activity with values for 18 in thrombin time of 0.63 mu M and in activated partial thromboplastin time of 2.0 mu M. B-11 NMR has been used to confirm interaction of the boron atom with the active site. From the high specificity shown with all the compounds we propose that the compounds, constitute a new class of thrombin inhibitors.
引用
收藏
页码:1511 / 1522
页数:12
相关论文
共 28 条
  • [1] CHARACTERIZATION OF A CLASS OF PEPTIDE BORONATES WITH NEUTRAL P1 SIDE-CHAINS AS HIGHLY SELECTIVE PRODRUG INHIBITORS OF THROMBIN
    DEADMAN, J
    ELGENDY, S
    GOODWIN, C
    GREEN, D
    BABAN, J
    PATEL, G
    SKORDALAKES, E
    CHINO, N
    CLAESON, G
    THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 924 - 924
  • [2] Thrombin inhibitors with nonbasic P1 side-chains
    Lloyd, AW
    DRUG DISCOVERY TODAY, 1998, 3 (08) : 388 - 388
  • [3] Elucidation of the thrombin inhibitory mechanism of tripeptide boronates with neutral P1 side chains
    Deadman, JJ
    Skordalakes, E
    Elgendy, S
    Green, D
    Goodwin, CA
    Claeson, G
    Scully, MF
    Kakkar, VV
    Gamblin, S
    Dodson, G
    THROMBOSIS AND HAEMOSTASIS, 1997, : P2024 - P2024
  • [4] STRUCTURE-FUNCTION ASPECTS OF NEUTRAL P1 RESIDUE PEPTIDE INHIBITORS OF THROMBIN
    DEADMAN, J
    CLAESON, G
    SCULLY, MF
    JOURNAL OF ENZYME INHIBITION, 1995, 9 (01): : 29 - 41
  • [5] Discovery of a novel, selective, and orally bioavailable class of thrombin inhibitors incorporating aminopyridyl moieties at the P1 position
    Feng, DM
    Gardell, SJ
    Lewis, SD
    Bock, MG
    Chen, ZG
    Freidinger, RM
    NaylorOlsen, AM
    Ramjit, HG
    Woltmann, R
    Baskin, EP
    Lynch, JJ
    Lucas, R
    Shafer, JA
    Dancheck, KB
    Chen, IW
    Mao, SS
    Krueger, JA
    Hare, TR
    Mulichak, AM
    Vacca, JP
    JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (23) : 3726 - 3733
  • [6] Discovery of a novel, selective, and orally bioavailable class of thrombin inhibitors incorporating aminopyridyl moieties at the P1 position
    Feng, DM
    Freidinger, RM
    Levis, SD
    Gardell, SJ
    Bock, MG
    Chen, ZG
    Naylor-Olsen, A
    Woltmann, R
    Baskin, EP
    Lynch, JJ
    Lucas, R
    Shafer, JA
    Dancheck, KB
    Chen, IW
    Vacca, JP
    PEPTIDES: FRONTIERS OF PEPTIDES SCIENCE, 1999, : 672 - 673
  • [7] Potent and selective TF/FVIIa inhibitors containing a neutral P1 ligand
    Miura, Masanori
    Seki, Norio
    Koike, Takanori
    Ishihara, Tsukasa
    Niimi, Tatsuya
    Hirayama, Fukushi
    Shigenaga, Takeshi
    Sakai-Moritani, Yumiko
    Kawasaki, Tomihisa
    Sakamoto, Shuichi
    Okada, Minoru
    Ohta, Mitsuaki
    Tsukamoto, Shin-ichi
    BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (23) : 7688 - 7705
  • [8] Potent and selective bicyclic lactam inhibitors of thrombin: Part 2: P1 modifications
    Plummer, JS
    Berryman, KA
    Cai, C
    Cody, WL
    DiMaio, J
    Doherty, AM
    Edmunds, JJ
    He, JX
    Holland, DR
    Levesque, S
    Kent, DR
    Narasimhan, LS
    Rubin, JR
    Rapundalo, ST
    Siddiqui, MA
    Susser, AJ
    St-Denis, Y
    Winocour, PD
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (23) : 3409 - 3414
  • [9] Potent and selective bicyclic lactam inhibitors of thrombin:: Part 3:: P1′ modifications
    Plummer, JS
    Berryman, KA
    Cai, CM
    Cody, WL
    DiMaio, J
    Doherty, AM
    Eaton, S
    Edmunds, JJ
    Holland, DR
    Lafleur, D
    Levesque, S
    Narasimhan, LS
    Rubin, JR
    Rapundalo, T
    Siddiqui, MA
    Susser, A
    St-Denis, Y
    Winocour, P
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (06) : 835 - 840
  • [10] Selectivity of Neutral/Weakly Basic P1 Group Inhibitors of Thrombin and Trypsin by a Molecular Dynamics Study
    Wu, Emilia L.
    Han, KeLi
    Zhang, John Z. H.
    CHEMISTRY-A EUROPEAN JOURNAL, 2008, 14 (28) : 8704 - 8714